ESC Congress 2007 RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST- ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA - II SUBSTUDY.

Slides:



Advertisements
Similar presentations
2/9/2014 The Prevalence and Prognostic Significance of ECG Abnormalities For: ECG in Ischemic Heart Disease By: V. Froelicher, MD Palo Alto VAHCS and Stanford.
Advertisements

CHEST PAIN Belgian Inter disciplinary Working group of Acute Cardiology Claeys MJ Vandekerckhove Y Bossaert L Calle P Martens P Hollanders G Vrints C Van.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
EKG Myocardial infarction and other ischemic states
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
Approach to Chest Pain. History “When it comes to chest pain, if you aren’t confident with your diagnosis after your history, take it again” Dr. M. Gamble.
STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients Bruce Brodie, Adam Bensimhon, Nathan Fleishman, Charles Hansen, Mike Cooper,
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
Cardiac memory distinguishes between new and old left bundle branch block Alexei Shvilkin, MD, PhD.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
VBWG OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Authors: Somkereki Cristina, Dr. Hadadi L.
The impact of pre-hospital thrombolytic treatment on re-infarction rates: Analysis of the Myocardial Infarction National Audit project (MINAP) Dr Simon.
Prehospital Fibrinolysis with Double Antiplatelet Therapy in Acute ST-Elevation Myocardial Infarction: The Clarity Ambulance Substudy Prehospital Fibrinolysis.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Author: Moldovan Carmen Co-authors: Opincariu Diana Balan Daniel University of Medicine and Pharmacy Tg. Mures Cardiology Clinic, Mures Emergency Clinical.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Diagnosis of Myocardial Infarction/Ischemia with Bundle Branch Blocks
Alternating bundle branch block  Alternating bundle branch block is diagnosed when conducted periods of RBBB and LBBB were noted in a patient on the.
RITA-3 ESC 4 th September 2005 The impact of underlying risk and gender on the benefit of early intervention in non-ST elevation acute coronary syndrome.
Acute Coronary Syndrome
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Acute Coronary Syndromes
Introduction Left bundle branch block (LBBB) is notorious for obscuring the ECG diagnosis of acute myocardial infarction (AMI) and, therefore, the decision.
Correlation between post-PTCA resolution of ST segment and mortality in STEMI patients First author: Diana Opincariu Co-authors: Carmen Moldovan Daniel.
Understanding the 12-lead ECG, part II By Guy Goldich, RN, CCRN, MSN Nursing2006, December Online:
Atypical Presentations Patients older than 75: frequently no chest pain ECG in evolution (nonspecific ECG changes) Diabetic patients: commonly no chest.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Myocardial Infarction and the ECG
Acute Coronary Syndrome
A Clinical profile of patients enrolled in the Pakistan ACS registry
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Figure 1 Ischaemic endpoints
ST T CHANGES Dr SRIKANTH KV MD DM ( CARDIOLOGY) SENIOR INTERVENTIONAL CARDIOLOGIST Specialist in Heart Failure Narayana Institute of Cardiac Sciences.
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP-India ACS Registry) Kunal Mahajan*, Negi PC,
The following slides highlight a presentation at the Late-Breaking Clinical Trials session of the American Heart Association Scientific Sessions, November.
ECG Lecture Scott Ewing, D.O. April 19, 2006.
Giuseppe Biondi Zoccai
Statins Evaluation in Coronary procedUres and REvascularization
European Heart Association Journal 2007 April
The Time Dependence of Anti-thrombin Initiation in Patients with Non-ST-segment –elevation Acute Coronary Syndrome: Subgroup Analysis form the ACUITY.
Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study.
Giuseppe Biondi Zoccai, MD
Invasive versus conservative treatment in unstable coronary syndromes
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
The European Society of Cardiology Presented by RJ De Winter
Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From.
Division of Cardiovascular Diseases No relevant author disclosures
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Global Registry of Acute Coronary Events: GRACE
Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome  Jonas Faxén, Hong Xu,
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Maintenance of Long-Term Clinical Benefit with
Management of AMI in patients presenting with STEMI
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
Presentation transcript:

ESC Congress 2007 RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST- ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA - II SUBSTUDY National Registry of Mexican Society of Cardiology Authors : Úrsulo Juárez MD FACC, Carlos Jerjes-Sanchez MD FACC, Eduardo Chuquiure MD, Carlos Martínez MD FACC On Behalf of RENASICA II and Sociedad Mexicana de Cardiología, México City, México.

BACKGROUND-1 Bundle branch block (BBB) early during acute myocardial infarction (AMI) is often considered high risk for mortality Bundle branch block (BBB) early during acute myocardial infarction (AMI) is often considered high risk for mortality In the Fibrinolytic Therapy Trialists’ meta-analysis, patients with BBB at randomization had a 35-day mortality rate of 24% without and 19% with fibrinolytic therapy. The studies included made no distinction between rigth bundle branch block (RBBB) and left bundle branch block (LBBB) and did not specify whether the BBB was new or old In the Fibrinolytic Therapy Trialists’ meta-analysis, patients with BBB at randomization had a 35-day mortality rate of 24% without and 19% with fibrinolytic therapy. The studies included made no distinction between rigth bundle branch block (RBBB) and left bundle branch block (LBBB) and did not specify whether the BBB was new or old Different types of BBB occurring during the initial hours of AMI may have different prognostic implications that are independient of another prognostic factors Different types of BBB occurring during the initial hours of AMI may have different prognostic implications that are independient of another prognostic factors ESC Congress 2007

BACKGROUND-2 Development of new BBB despite prompt fibrinolytic therapy may signify an extensive and ongoing AMI. Some types of BBB may reflect larger infarct territories, indicating that these patients might benefit from more aggressive reperfusion therapy Development of new BBB despite prompt fibrinolytic therapy may signify an extensive and ongoing AMI. Some types of BBB may reflect larger infarct territories, indicating that these patients might benefit from more aggressive reperfusion therapy Until our knowledgment the prognosis of RBBB in patients with acute coronary syndromes is unclear Until our knowledgment the prognosis of RBBB in patients with acute coronary syndromes is unclear Reference : European Heart Journal (2006)27,21-28 ESC Congress 2007

METHODS-1 The RENASICA II Design overview The RENASICA II Design overview Is the largest national registry of ACS recruited 8,098 patients with final diagnosis of ACS ST elevation (STE) or non-ST elevation (NSTE) secundary to ischaemic heart disease and designed to characterize an unbiased and representative population Is the largest national registry of ACS recruited 8,098 patients with final diagnosis of ACS ST elevation (STE) or non-ST elevation (NSTE) secundary to ischaemic heart disease and designed to characterize an unbiased and representative population The patients were enrrolled in 66 primary and tertiary Mexican Hospitals and for quality control criteria af Alpert were used. The hospitals varied in terms of access to on-site cardiac catheterization, number of acute care beds and the type of practice setting with an aim of stlablishing a representative rather than selective study population The patients were enrrolled in 66 primary and tertiary Mexican Hospitals and for quality control criteria af Alpert were used. The hospitals varied in terms of access to on-site cardiac catheterization, number of acute care beds and the type of practice setting with an aim of stlablishing a representative rather than selective study population ESC Congress 2007

METHODS – 2 : Patients with ST acute myocardial infarction (AMI) with LBBB or RBBB were compared in terms of in-hospital outcome and major cardiovascular adverse events (MACE), cardiovascular death, myocardial infarction (MI) and recurrent ischaemia Patients with ST acute myocardial infarction (AMI) with LBBB or RBBB were compared in terms of in-hospital outcome and major cardiovascular adverse events (MACE), cardiovascular death, myocardial infarction (MI) and recurrent ischaemia patients with symptoms precipitated by anemia,hypertension, heart failure, etc were excluded patients with symptoms precipitated by anemia,hypertension, heart failure, etc were excluded BBB was defined as de the QRS duration of 0.12 sec in precence sinus or supraventricular rhythm BBB was defined as de the QRS duration of 0.12 sec in precence sinus or supraventricular rhythm Multivariable Analysis was performed to identify in hospital mortality risk among RBBB and LBBB with MACE Multivariable Analysis was performed to identify in hospital mortality risk among RBBB and LBBB with MACE Odd ratio (OR) and confidence intervals 95% (CI) Odd ratio (OR) and confidence intervals 95% (CI) ESC Congress 2007

Inclusion Criteria Inclusion Criteria INCLUSION (4) 1. lchemic Chest Pain > 20 min 2. ST-E: in BL > 1 mm; Precordial leads > 2 mm 3. QRS duration > 0.12 seg. 4. Complete Register Form – Signed IC 4. Complete Register Form – Signed IC EXCLUTION (1) 1. Non Ischaemic CP precipitated by secundary cause as anemia, heart failure or hypertension 2. Previous BBB 3. Pacemaker rythm 2. Previous BBB 3. Pacemaker rythm RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY ESC Congress 2007

To ensure quality control of registry data the following criteria developed by Alpert were applied in RENASICA II: a)Standarizad definitions and all participants were familiarizad b)Careful hospitals selection c)Hospitals approved registry data collection process d)All collected data were reported e)Original data,electronic submissions were centralized f) A professional statistician analyzed the data g)All data and electronic submissions were examined by the central data management h)Principal investigator and steering committee keep administrative order, adjudicated disagreements and encouraged timely submission of documents and data analysis. ESC Congress 2007 QUALITY

RESULTS 4,555 patients with STE AMI were analyzed in this substudy 4,555 patients with STE AMI were analyzed in this substudy Of them 7% had RBBB and 5% LBBB Of them 7% had RBBB and 5% LBBB There were not statistical differences in both groups among aged, gender baseline characteristics, onset symptoms, ischemic time, AMI location, Killip functional class, ventricular dysfunction, and reperfusion strategies. There were not statistical differences in both groups among aged, gender baseline characteristics, onset symptoms, ischemic time, AMI location, Killip functional class, ventricular dysfunction, and reperfusion strategies. Patients with inferior or anterior STE AMI with RBBB had highest mortality and association with MACE ( OR 1.70, CI 1.19 – 2.42, p< compared to LBBB. Patients with inferior or anterior STE AMI with RBBB had highest mortality and association with MACE ( OR 1.70, CI 1.19 – 2.42, p< compared to LBBB. ESC Congress 2007 RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY

RBBB n= 318 (7%) LBBB n= 227 (5%) Unspeciphic Chest Pain n = 625 (7%) Unspeciphic Chest Pain n = 625 (7%) UA / Non ST AMI* n = 3,445 (40%) UA / Non ST AMI* n = 3,445 (40%) STE AMI** n = 4,555 (53%) n = 8,098 Patients with ACS * UA/Non ST AMI = Unstable Angina No ST elevation acute myocardial infarction ** STE AMI = ST elevation acute myocardial infarction RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY ESC Congress 2007

RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY ACS-AMI-ST ELEVATION RENASICA – II REGISTRY n = 4,555 STEMI RIGTH BUNDLE BRANCH BLOCK N = 318 ( 7% ) In Hospital Outcome – Major Cardiovascular Adverse Events – Cardiovascular Death Recurrent ischemia – Re AMI Multivariable Analysis to In Hospital Mortality Risk among RBBB and LBBB with MACE Odd Ratio (OR) and Confidence Intervals 95% LEFT BUNDLE BRANCH BLOCK N = 227 ( 5% ) BBB n = 545 patients ESC Congress 2007

Baseline Characteristics-1 Baseline Characteristics RBBB (n=318) 35 Previous AMI (%) 59 Hypertension (%) 26 Hyperlipidemia (%) 66 Current/former smoker (%) 47 Diabetes (%) 71 Men (%) 67.3 Age-years- median LBBB (n=227) Characteristic all p = NS ESC Congress 2007

RBBB (n=318) K Killip I (n =) II II III III IV IV 2316 AMI location (%) AnteriorInferior LBBB (n=227) Characteristic All p = NS Baseline Characteristics-2 Baseline Characteristics-2 ESC Congress 2007

TREATMENT TREATMENT RBBB (n=318) 59 IECA/ARB (%) 89 ASA (%) 51 Beta Bloq.(%) LBBB (n=227) Medication 1413 Statins (%) all p = NS Reperfusion Strategy Lytic (%) Primary PTCA (%) Clopidogrel (%) ESC Congress 2007

Outcomes in Hospital Comparison in both BBB and MACE P value = ns % LBBB RBBB * ESC Congress

LBBB RBBB 3 rd degree AV block ST Depresion in > 3 ECG leads (OR 1.7, CI 1.1 – 2.5) (OR 1.7, CI 1.1 – 2.4) (OR 2.4, 95% CI 1.9 –3.1) findings ECG IN HOSPITAL MORTALITY PREDICTORS IN STEMI A SUBSTUDY OF RENASICA II logistic regresion in mortality predictors ESC Congress 2007

Clinical Implications The higher mortality and higher incidence of RBBB seen in patients with anterior AMI may be axplained by: The higher mortality and higher incidence of RBBB seen in patients with anterior AMI may be axplained by: Septal ischaemia from a more proximal left descending artery occlusion (before the large septal branch) Septal ischaemia from a more proximal left descending artery occlusion (before the large septal branch) The course of the rigth bundle branch traversing the septum towards the apex. The course of the rigth bundle branch traversing the septum towards the apex. Limitations As in all clinical trials, a selection bias could have occurred in RENASICA II resulting in under-representation of very high risk patients (including those with RBBB accompanying anterior AMI) in the trial cohort. As in all clinical trials, a selection bias could have occurred in RENASICA II resulting in under-representation of very high risk patients (including those with RBBB accompanying anterior AMI) in the trial cohort. ESC Congress 2007

Conclusion The RBBB accompanying anterior or inferior AMI at presentation was an independient predictor of high in hospital mortality. These electrocardiographics features should be considered in risk stratification to identify high- risk patients ESC Congress 2007 RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA- II SUBSTUDY